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Abstract

Author Manuscript

Background—Healthcare-associated infections (HAIs) are preventable. Globally, laws aimed at
reducing HAIs have been implemented. In the USA, these laws are at the federal and state levels.
It is not known whether the state interventions are more effective than the federal incentives alone.
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Objective—The aims of this study were to explore the impact federal and state HAI laws have
on state departments of health and hospital stakeholders in the USA and to explore similarities and
differences in perceptions across states.
Methods—A qualitative study was conducted. In 2012, we conducted semistructured interviews
with key stakeholders from states with and without state-level laws to gain multiple perspectives.
Interviews were transcribed and open coding was conducted. Data were analysed using content
analysis and collected until theoretical saturation was achieved.

Author Manuscript

Results—Ninety interviews were conducted with stakeholders from 12 states (6 states with laws
and 6 states without laws). We found an increase in state-level collaboration. The publicly
reported data helped hospitals benchmark and focus leaders on HAI prevention. There were
concerns about the publicly reported data (eg, lack of validation and timeliness). Resource needs
were also identified. No major differences were expressed by interviewees from states with and
without laws.
Conclusions—While we could not tease out the impact of specific interventions, increased
collaboration between departments of health and their partners is occurring. Harmonisation of HAI
definitions and reporting between state and federal laws would minimise reporting burden.
Continued monitoring of the progress of HAI prevention is needed.

BACKGROUND

Author Manuscript

For over 15 years, public disclosure of hospital outcome data has been thought to improve
patient safety.1 One of the most serious issues for ensuring patient safety is preventing
healthcare associated infections (HAIs); at any given time, an estimated 1 in 25 hospitalised
patients in the USA has a HAI, leading to significant morbidity and mortality.2 The Centers
for Disease Control and Prevention (CDC) estimated the annual national hospital costs of
HAI to be US$25–31 billion.3 These data, coupled with growing demand for transparency
and accountability by policy makers, have led several countries to legally mandate the
public reporting of HAI indicators including England, France and the USA.4
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In the USA, HAI reporting laws have been enacted at the federal and state levels.56 In 2008,
the federal Department of Health and Human Services implemented a national Action Plan
for reducing HAIs across healthcare and identifying measureable goals.7 In support of the
Action Plan, further federal initiatives were legislated. For example, as part of the American
Recovery and Reinvestment Act of 2009 (Public Law 111-5, 42 U.S.C 241(a)), US$40
million were appropriated through the CDC. These funds were available to all states to
support state departments of health (DOH) for HAI prevention planning and infrastructure
including supporting a state-specific dedicated programme coordinator (HAI coordinator).
As part of the Patient Protection and Affordable Care Act of 2010 (Public Law 111–148),
the Hospital Value Based Purchasing Program built on earlier legislation that allowed
Medicare to pay hospitals for reporting quality measures, rather than on the quantity of care
(eg, service or patient counts). This programme included the Inpatient Quality Reporting
Program requiring hospitals to report specific HAIs to the CDC’s National Healthcare
Safety Network to receive full Medicare payment.
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The federal laws apply across all 50 states and provide incentives only; these interventions
do not mandate action. As of 2013, 37 states (including the District of Columbia and Puerto
Rico) have introduced laws that require facilities to report HAI indicators to each state’s
DOH, which then may report HAI data publicly.8 While there is support of the general
concept of HAI prevention, the evidence on the benefits of public reporting has been
inconclusive and opinions are mixed.910 Furthermore, it is not known whether the state
interventions are more effective than the federal legislation alone. Therefore, our aims were
to explore the impact federal and state HAI laws have on state DOH and hospital
stakeholders in the USA and to explore the similarities and differences in perceptions from
those in states with and without state-level laws.

STUDY DESIGN AND METHODS
Author Manuscript

Our research team conducted a qualitative public health law study.11–13 This design was
chosen because of its inductive nature, which may provide invaluable insights from multiple
perspectives.
Selection of states

Author Manuscript

First, a legal review was conducted to determine the states that had HAI reporting laws.
LexisNexis research system databases were used along with other relevant administrative
law resources to capture state statutes and administrative regulations. To ensure accuracy,
HAI coordinators in states and territories with legal reporting mandates (n=36 at the time of
our study) were contacted and verification was obtained. Figure 1 displays all states with
and without mandatory reporting laws as of 1 May 2012. States were purposefully sampled
to include equal numbers of those with and without state-level mandatory reporting laws and
to ensure geographical variety until theoretical saturation was achieved.
Selection of participants
From each of the states, stakeholders with key roles (ie, state DOH HAI personnel,
regulatory or legal officials, clinicians and community partners) were purposefully recruited
to elicit multiple perspectives. Using a snowballing technique, each state’s HAI coordinator
was asked to recommend knowledgeable individuals from each role. At least 5 and up to 10
participants were recruited from each state based on availability, willingness to participate
and theoretical saturation.
Interviews

Author Manuscript

Semistructured interview guides (available upon request) were tailored to the key roles and
state type (ie, state-level law or no law). These guides were based on: (1) Donabedian’s
quality framework that proposes evaluation of healthcare delivery should be based on the
quality of system structure, process and outcomes, (2) our legal review and (3) knowledge
gained from previous research.514–16 All interview guides included demographic and openended questions about the impact state and federal laws have on structure of the state HAI
programme; changes in the programme; working relationships in HAI prevention;
community and non-governmental partnerships; HAI data uses; funding; and lessons
learned.
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A two-person interview team was trained by the investigators (PWS and JAM) so there
would be consistent interviewing techniques used.17 Prior to beginning, the interview team
piloted all procedures. Interviews were audiotaped, professionally transcribed and reviewed
for accuracy.
Analysis

Author Manuscript

Transcripts were entered into NVivo 10 (QSR International) software and identified by state
and role only. All data were combined. Transcripts were read several times by multiple team
members to gain an understanding of the data. An inductive open coding process was
conducted by two research assistants who were supervised by the investigators (PWS and
JAM). Coding began as soon as transcripts were received and throughout the coding
process, two transcripts were double coded on a bi-weekly basis and per cent agreement was
computed and adequate (ie, >90%). Discrepancies were discussed until a consensus was
reached. Throughout the interviewing and coding process, weekly debriefings occurred with
all research team members to ensure a shared understanding of the data. Using a qualitative
content analysis approach,18 coded data were reviewed to develop themes, looking for
similarities and differences between respondents from states with and without state-level
laws. This comprehensive, conscious and collaborative analysis contributes to the credibility
of the findings.

RESULTS

Author Manuscript

Theoretical saturation was achieved after recruiting 12 states (see figure 2). Of the states
with HAI mandatory reporting laws, Arkansas, Colorado, New York, Ohio, Tennessee and
Texas were selected (randomly assigned numbers from 1 to 6). Arizona, Georgia, Kansas,
Kentucky, Nebraska and Wisconsin were states selected without laws (randomly assigned
numbers from 7 to 12).
Ninety interviews were conducted and the respondent roles included: (1) state DOH officials
and HAI coordinators; (2) DOH regulatory officials and legal counsel; (3) clinicians
involved in HAI prevention including infection preventionists (IPs), hospital
epidemiologists, and department managers from acute care and specialty care settings (eg,
dialysis); and (4) community partners including state hospital association representatives,
quality improvement organisation representatives, and if applicable, consumer advocates.
Table 1 describes the key stakeholders by state type. A majority (59%) came from states
with HAI laws.

Author Manuscript

Our findings are organised around four themes: increased collaboration, using public
reported data for benchmarking and prioritising, concerns related to public reported data and
resource needs. Narrative exemplar quotes supporting each theme from the various
stakeholders from states with and without laws are provided below. Table 2 displays the
narratives consistent with the themes by role and state type. There is some dissimilarity in
the narrative responses by role (ie, only 50% of regulatory or legal stakeholders discussed
resource needs compared with 70–80% of the other stakeholders). The narratives are similar
from stakeholders from states with and without state-level laws.
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Many respondents commented on the increase in state-level partnerships and collaboration
stemming from the HAI laws. For example, one respondent stated:
Before [the federal HAI prevention actions] we were … working alone in our own
little spheres and not necessarily discovering what other places are doing.
(Participant 56, IP, state 7)
Indeed, collaboration came up repeatedly in discussions about Quality Improvement
Organizations, Hospital Engagement Networks (ie, learning collaboratives funded through
the federal government), hospital associations and DOHs. As one respondent discussed:

Author Manuscript

…we try to coordinate the work between state [DOH], and state hospital
association, and the HEN [hospital engagement network] work, and then what I’m
doing, so we’re not reinventing the wheel and duplicating efforts. (Participant 72,
quality improvement organization representative, state 11)
Furthermore, many recognised the state DOH as leading these collaborations as elucidated
below:
The state is leading …getting the right people in the room, distribution across the
state, different types of providers, stakeholders, infection preventionists, other
disciplines. There’s somebody knowledgeable at the state level very involved.
(Participant 39, hospital association representative, state 4)
This respondent also discussed the collaboration between the hospital association and the
hospitals as follows:

Author Manuscript

We’re very hands-on. We’ve become an extension of each hospital’s team and use
regional expertise to coach and mentor hospitals. (Participant 39, hospital
association representative, state 4)
Using publicly reported data for benchmarking and prioritising
Publicly reported data were useful in obtaining the focus of the hospital administrators and
gaining support for local prevention efforts. It was perceived that state and federal level HAI
reporting laws influenced the prioritisation of infection prevention efforts. Due to
institutional accountability and reputation, the publicly reported data helped hospitals
benchmark and focus leaders on HAI prevention. This benchmarking often translated into an
increased recognition of the importance of infection prevention in the facility as explained
below:

Author Manuscript

When you take data…put names along with it…put it on a website or in the
newspaper…you see monumental change in the interest and funding that the CEO
[Chief Executive Officer] provides. (Participant 14, community representative,
state 2)
The data resulting from the state reporting mandate were useful for prioritising state
prevention efforts as described in the following:
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A few years ago we added C. difficile infections…based on what we’re seeing in
the state [publically reported data]. (Participant 21, HAI coordinator, state 4)
Benchmarking and prioritising was also present in states without state-level mandatory
reporting laws as described:
We provide benchmarking for both individual hospitals and then compare it [to]
state and national data when [they are] available. And we provide targeted
interventions and resources to hospitals that are having challenges in bringing those
rates down. (Participant 51, hospital association representative, state 9)
Concerns related to publicly reported data

Author Manuscript

There were concerns about the data reported as a result of the HAI laws. These concerns
stemmed from a need for validation and standardisation of definitions as well as the
specificity and timeliness of the aggregated publicly reported data to inform practice. As
discussed below, inconsistently defined data for benchmarking between institutions was
seen as problematic:
The worry would be whether everybody was collecting data the same way and if
we were capturing really what we thought we were capturing. (Participant 46, IP,
state 7)
Many stakeholders expressed doubts about using unvalidated data as described:
Data validation is also important. You know there are quite a few states that publish
reports, but the data aren’t validated. (Participant 27, DOH official, state 4)
The concern about validation was echoed in the following statement:

Author Manuscript

We’re collecting all of this information, but we haven’t validated the data, and
while I trust that we have a very savvy and robust network of IPs, I think folks
would feel a lot more comfortable with the data knowing that some validation has
occurred. (Participant 65, DOH official, state 10)
Others were concerned about the timeliness and specificity of the data; state-specific data
were perceived as timelier than federal data as described in the following:
When it comes to CMS [Centers for Medicare and Medicaid Services] reporting, by
the time they get that data out…it doesn’t have as much relevance because it’s…24
months old or 18 months old…versus the state [DOH] HAI data, which is very
specific. (Participant 28, community representative, state 5)

Author Manuscript

Resource needs
Sustainable and sufficient funding for the state level programmes was an issue. In all states,
respondents discussed resource constraints and stressed the need for sustainable and
sufficient funding for the state HAI programme. Many respondents expressed the belief that
their state’s HAI programme would not exist without a federal investment and expressed
concern that this funding was unreliable as explained below:
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ARRA [American Recovery and Reinvestment Act] was huge for us. We wouldn’t
have the [state HAI] program…the state [HAI program] has to have funding. I
don’t know how the government can come up with the [future] funding, but you
know somehow, [in] some way that needs to happen. (Participant 33, regulatory
stakeholder, state 5)
These sentiments were echoed in the following:
Our biggest issue is ongoing funding. So that’s worrisome when [the state HAI
program is] 100% federally funded. (Participant 59, HAI coordinator, state 5)
Another important aspect of resources was trained personnel. The need for sufficient
numbers of personnel with adequate, relevant expertise was discussed by respondents from
all states. For example, one respondent stated:

Author Manuscript

It’s really hard to build expertise. It’s hard enough at the state level to get expertise,
to help these IPs out. At the hospital level there often aren’t enough trained IPs.
(Participant 88, DOH official, state 12)
Many stakeholders expressed concern that meeting reporting requirements (ie, federal and
state) overburdened the IPs leaving little time for development and execution of
interventions aimed at prevention. As one respondent explained:

Author Manuscript

Many of our IPs complain that they’re spending all of their time doing data entry,
collection and management and have very little time for education and infection
prevention efforts. When you’re spending all of your time collecting all this
different data, there is not enough time to actually do the infection prevention
effort, so those are unintended consequences. (Participant 28, community
representative, state 5)

DISCUSSION
We explored perceptions of the impact federal and state HAI laws have on state DOHs and
hospital stakeholders in the USA and similarities and differences in perceptions from those
working in states with and without state-level laws. While some findings were expected
others were surprising.

Author Manuscript

We found there was a perception that state HAI laws fostered a climate of collaboration.
There is a growing evidence base establishing the efficacy of HAI prevention collaboratives
that emphasise health system change through surveillance, data feedback, systematic
implementation of prevention measures, and intrafacility and interfacility collaboration.19–21
Other researchers have surveyed DOH about their HAI prevention activities and found that
between 2009 and 2011, just prior to our study period, federal funding had resulted in 60
prevention collaboratives.22 Therefore, it is not surprising that we found increased
partnerships described by interviewees in all states. What was not known was the
partnerships were frequently attributed to the role the state DOH played as a convenor and
leader.
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Stakeholders from both types of states (ie, with state-level laws and without) discussed how
the publicly reported data were used to benchmark and prioritise HAI prevention efforts.
The federal financial incentives were perceived to be an important motivator for healthcare
facility prevention efforts. This is despite a lack of evidence on the efficacy of the federal
incentives; in 2008, researchers found that federal non-payment policy did not affect rates of
targeted HAIs.23 However, that research only focused on the non-payment policy, which
was found to have negligible impact on hospital finances.24 The more recent value-based
purchasing programme may act as a stronger financial incentive. Even without clear
evidence of the efficacy of financial incentives, publicly reported data were considered
useful for engaging institutional leadership around issues of harm reduction and reputation.

Author Manuscript

It is not surprising that validation of publicly reported data and use of standard definitions
were seen as paramount by stakeholders. The importance of data validation has been
recognised by the CDC.25 Without validation, there may be incentives to under-report due to
the data being tied to payment and hospital reputation. In Europe, due to concerns about
under-reporting as well as potential to negatively impact prevention efforts, experts are in
favour of reporting process indicators over HAI rates.10

Author Manuscript

The timeliness and specificity of the data were persistent concerns among the respondents, a
problem also identified in prior CDC HAI stakeholder engagement activities.514 The benefit
of rapid-cycle feedback to clinicians and hospital administration is well known26 and given
sufficient staffing, facilities would be expected to provide feedback to clinicians directly
while providing their state DOH with data. Indeed, the CDC’s National Healthcare Safety
Network provides two mechanisms for facilities to voluntarily share HAI data with their
state DOH: the National Healthcare Safety Network Group Function and data use
agreements between the CDC and individual state DOHs. These resources afford states and
the individual hospital immediate access to data to focus prevention efforts.
Sustainable resources and funding for HAI programmes were identified as important
themes. State DOHs that are facing budget cuts depend on vulnerable programmatic funding
streams and must balance competing priorities against scarce resources.27 Targeted funding
can play a critical role in reducing HAIs.21 While increased resources for infectious disease
epidemiology and laboratory capacity have recently been awarded through the CDC, future
funding is not guaranteed.28

Author Manuscript

Respondents repeatedly expressed a need for experienced personnel, especially IPs. Over the
past few decades, the role of IPs has changed.29 IPs have shifted their focus from merely
monitoring infections to proactively intervening to prevent them and have expanded their
scope to lead performance improvement teams.30 However, with mandatory reporting, some
IPs are forced to spend more time on surveillance and less time on preventing infections.31
While the focus of responses varied slightly by role, we were surprised we did not uncover
major differences in those from states with or without state reporting laws. We attribute this
to the impact of federal HAI prevention initiatives on stakeholders in all states. It is possible
that the state laws had an impact on healthcare delivery processes and may have laid the
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groundwork for the federal legislation. However, we cannot definitively determine that
impact with our current data.
Limitations
This study has limitations; findings need to be interpreted with caution. Efforts were made to
have a diverse sample of states and respondents to gain multiple perspectives. However, the
respondents did not represent all states and the findings may have limited transferability.
The data are narrative self-report and bias due to social desirability cannot be ruled out.

CONCLUSIONS

Author Manuscript

Legal interventions such as state-level reporting mandates and value based purchasing
federal incentives should be, in theory, associated with decreasing HAIs. While we could
not tease out the impact of specific interventions, progress has been made in the effort to
eliminate HAIs; however, more work is needed to improve patient safety and reduce HAIs.
Continued monitoring of the progress made towards goals to decrease HAIs is needed. To
prevent HAIs, collaboration between public health agencies and their partners in the
healthcare sector is essential. Harmonisation of HAI definitions and reporting between state
and federal laws would minimise reporting burden.
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Figure 1.

Map of states with healthcare-associated infection laws.
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Figure 2.

States participating in the study.
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Key respondents from each type of state
State categories
With laws* (n=6)

No laws† (n=6)

DOH official

3

5

8

HAI coordinator

6

5

11

State DOH regulatory official

4

3

7

State DOH legal counsel

6

1

7

14

9

23

4

3

7

Hospital association

6

5

11

QIO

6

4

10

Consumer advocate

4

2

6

53

37

90

Role

Total

State DOH HAI personnel

Regulatory or legal

Clinicians
Acute care facility IP/HE
Specialty care facility IP/HE

Author Manuscript

Community partners

Total personnel interviewed
*

Arkansas, Colorado, New York, Ohio, Tennessee, Texas.

†

Arizona, Georgia, Kansas, Kentucky, Nebraska, Wisconsin.

DOH, Department of Health; HAI, healthcare-associated infection; HE, hospital epidemiologist; IP, infection preventionist; QIO, quality
improvement organisation.
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9 (100)
9 (100)

Concerns related to publicly reported data

Resource needs

DOH, Department of Health; HAI, healthcare-associated infections.

States without laws; N=number of interviewees.

†

States with laws

*

7 (78)

Using publicly reported data for benchmarking and
prioritising

8 (80)

10 (100)

8 (80)

10 (100)

5 (50)

7 (70)

8 (80)

8 (80)

9 (100)

Increased collaboration

2 (50)

3 (75)

3 (75)

3 (75)

No† N=4 (%)

Yes* N=10 (%)

Yes* N=9 (%)

State law status

No† N=10 (%)

Regulatory or legal

DOH HAI personnel

17 (94)

15 (83)

17 (94)

13 (72)

Yes* N=18 (%)

Clinicians

Author Manuscript

Percentage of respondents in states with and without laws that contributed data to the themes

11 (92)

9 (75)

12 (100)

12 (100)

No† N=12 (%)

14 (88)

9 (56)

14 (88)

14 (88)

Yes* N=16 (%)

10 (91)

9 (82)

10 (91)

11 (100)

No† N=11 (%)

Community partners
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